The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s epigenetics market report forecasts the epigenetics market size to grow to $18.21 Billion by 2027, with a CAGR (compound annual growth rate) of more than 19%.

Learn More On The Epigenetics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Epigenetics Market Size Forecast
The global epigenetics market is expected to grow from $7.38 billion in 2022 to $8.85 billion in 2023 at a compound annual growth rate (CAGR) of 20.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The epigenetics market size is expected to grow to $18.21 billion in 2027 at a CAGR of 19.8%.

North America held the largest epigenetics market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Epigenetics Market Driver ­– Growth In The Prevalence Of Cancer And Other Diseases
According to the European Commission’s Joint Research Centre from Ispra, the number of new cancer cases in the European Union (EU) and European Free Trade Association (EFTA) countries will rise by 21.4%, from 2.8 million in 2020 to 3.4 million in 2040. Furthermore, according to the Centers for Disease Control and Prevention (CDC), approximately 659,000 people in the United States die of heart disease each year. The increasing prevalence of cancer and other diseases requires testing and knowing the modifications that happened in the genes, which will invariably increase the usage and demand of epigenetics. Thus, the growing prevalence of cancer and other diseases drives the epigenetics market in the coming years.

Request for A Sample Of The Global Epigenetics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Key Epigenetics Market Trend – Technological Advancement
The key players in the epigenetics sector are focusing on developing various technologically advanced products and services to strengthen their position in the market. For instance, in May 2021, Givaudan Active Beauty, a Switzerland-based company specialising in fragrance, beauty, taste and wellbeing, launched Chronoglow. Chronoglow is a skin-care-beneficial active component created by green fractionation and supported by artificial intelligence (AI) that can replicate natural epigenetic mechanisms. Chronoglow is a natural skin remedy made from Haberlea rhodopensis, often known as the resurrection plant, which can improve the skin’s luminosity and reverse the signs of aging.

Epigenetics Market Segment
1) By Product: Reagents, Enzymes, Instruments, Kits
2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures
3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications
4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organisations, Other End Users

Epigenetics Market Major Players and Strategies
Major players in the epigenetics market are Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad, New England Biolabs, Agilent, Qiagen, Zymo Research, Perkinelmer, Diagenode, Hoffmann-La Roche Ltd., Eisai Co Ltd and Novartis AG.

In December 2020, Exact Sciences, a US-based molecular diagnostic company, acquired Base Genomics for $140 million. As a result of this acquisition, Exact Sciences aims to create a multi-cancer early detection blood test. This acquisition also aids in the acceleration of clinical and commercial development. Base Genomics is a UK-based epigenetics company working on designing a blood test for minimal residual disease and early-stage cancer.

The Epigenetics Global Market Report 2023 covers regional data on epigenetics market size, epigenetics market trends and drivers, opportunities, strategies, and epigenetics market competitor analysis. The countries covered in the epigenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Epigenetics is a change in gene activity transmitted to younger cells without modifying the DNA sequence. Epigenetic processes are natural and necessary for many organisms to work, but unusual occurrences can cause disorders, such as various types of cancer, reproductive illnesses, and cardiovascular illnesses. Epigenetics is used detect a type of cancers earlier.

View More Reports Related To The Epigenetics Market –
Bioinformatics Global Market Report 2023
Cancer Tumor Profiling Global Market Report 2023
Small Animal Imaging Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: